ArticleBMC cardiovascular disorders2026
The relationship between cardiovascular risk level determined by SCORE2 and cardiovascular disease risk awareness and health literacy in individuals aged 40-69: a cross-sectional study.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCardiovascular diseases (CVD) are a major cause of morbidity and mortality worldwide. Individuals’ awareness of cardiovascular risk and levels of health literacy play a critical role in the prevention of CVD. This study aimed to evaluate the relationship between cardiovascular risk level calculated using SCORE2 and awareness of cardiovascular disease risk and health literacy among individuals aged 40–69 years. MATERIALS AND
methodsThis cross-sectional analytical study was conducted in 2025 among individuals aged 40–69 years who attended the Family Medicine outpatient clinics at Ankara Bilkent City Hospital. Participants were recruited using a convenience sampling method. Individuals who were aged 40–69 years, had undergone the necessary blood tests required for SCORE2 calculation within the last six months, were able to communicate in Turkish, and provided informed consent were included in the study. Data were collected through face-to-face interviews using sociodemographic information, the Cardiovascular Disease Risk Awareness Assessment Scale (KHRDÖ), the Turkish Health Literacy Scale-32 (TSOY-32), and the SCORE2 risk assessment system. Statistical analyses were performed using IBM SPSS Statistical analyses were performed using IBM SPSS Statistics 26.0 software. Spearman correlation analysis was used to evaluate the relationships between variables.
resultsParticipants’ KHRFDÖ scores indicated a moderate level of cardiovascular risk awareness, while TSOY-32 results showed that a considerable proportion of individuals had “inadequate” or “problematic-limited” health literacy levels. According to the SCORE2 classification, a substantial proportion of participants were in the high and very high cardiovascular risk groups. A weak but statistically significant positive correlation was observed between SCORE2 and the perceived heart attack and stroke risk sub-dimension of KHRFDÖ (r = 0.180; p = 0.001). In addition, significant but weak positive correlations were found between health literacy levels and several sub-dimensions of cardiovascular risk awareness.
conclusionA weak positive association was observed between objectively calculated cardiovascular risk and perceived risk of heart attack and stroke. These findings suggest that objective cardiovascular risk assessment tools such as SCORE2 may provide additional value when considered together with cognitive and behavioural factors such as health literacy and risk awareness in primary care settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.